Qt Creator relies on some submodules, like litehtml for displaying documentation. Get these submodules with cd ... Windows are faster due to profile-guided optimization. If the prebuilt packages do ...

The best IRA CD rates offer guaranteed returns, making them an attractive option for savers who want a low-risk and steady way to grow their savings. If you’re looking for the best IRA CD rates ...

And what better way to celebrate the occasion than with a free Game & Watch-style haunted house caper from Papers, Please and Obra Dinn creator Lucas Pope? The wonderfully titled Moida Mansion is ...

Where you park your funds determines how much interest you’ll earn. We outline the best CD rates in Wisconsin to help you maximize your money, along with information on how much you can earn ...

Now it's been revealed that its creator Patrick Horvath is set to launch ... from high-profile creators planned for Spring 2025. Free For All is described as a "gory and gripping" 56-page one ...

CD rates move in tandem with the federal funds rate, the benchmark interest rate set by the Federal Reserve. Yields on CDs rose above 10% in the early 1980s when the Fed set interest rates well ...

Microsoft has made Windows Update significantly faster in its latest big update to Windows 11. Version 24H2 started rolling out earlier this month with lots of useful improvements, but now ...

French pharmaceutical group Sanofi and US private equity firm Clayton Dubilier & Rice (CD&R) have entered exclusive negotiations regarding the partial takeover of Sanofi subsidiary Opella.

The firm, CD&R, is attempting to acquire control of Sanofi subsidiary Opella, which manufactures over-the-counter drugs like paracetamol. Sanofi announced on Monday that it had entered exclusive talks ...

The renewed negotiations come after CD&R agreed to pledges around local ... over a French rival as the frontrunner to acquire the maker of Doliprane painkiller earlier this month.

"Our demands on employment, production and investment will be respected," Armand said on X, apparently authorizing the sale of Sanofi's over-the-counter drug unit Opella to US investment fund CD&R.